2,176
Views
27
CrossRef citations to date
0
Altmetric
Short Report

Intravital characterization of tumor cell migration in pancreatic cancer

, , , &
Article: e1261773 | Received 06 Apr 2016, Accepted 10 Nov 2016, Published online: 18 Nov 2016

References

  • Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, Rustgi AK, Chang S, Tuveson DA. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 2005; 7:469-83; PMID:15894267; http://dx.doi.org/10.1016/j.ccr.2005.04.023
  • Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009; 324:1457-61; PMID:19460966; http://dx.doi.org/10.1126/science.1171362
  • Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012; 148:349-61; PMID:22265420; http://dx.doi.org/10.1016/j.cell.2011.11.025
  • Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, Kalluri R. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 2015; 527:525-30; PMID:26560028; http://dx.doi.org/10.1038/nature16064
  • Ellenbroek SI, van Rheenen J. Imaging hallmarks of cancer in living mice. Nat Rev Cancer 2014; 14:406-18; PMID:24854083; http://dx.doi.org/10.1038/nrc3742
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
  • Beerling E, Ritsma L, Vrisekoop N, Derksen PW, van Rheenen J. Intravital microscopy: new insights into metastasis of tumors. J Cell Sci 2011; 124:299-310; PMID:21242309; http://dx.doi.org/10.1242/jcs.072728
  • Fein MR, Egeblad M. Caught in the act: revealing the metastatic process by live imaging. Dis Model Mech 2013; 6:580-93; PMID:23616077; http://dx.doi.org/10.1242/dmm.009282
  • Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147:275-92; PMID:22000009; http://dx.doi.org/10.1016/j.cell.2011.09.024
  • Sahai E. Mechanisms of cancer cell invasion. Curr Opin Genet Dev 2005; 15:87-96; PMID:15661538; http://dx.doi.org/10.1016/j.gde.2004.12.002
  • Friedl P, Locker J, Sahai E, Segall JE. Classifying collective cancer cell invasion. Nat Cell Biol 2012; 14:777-83; PMID:22854810; http://dx.doi.org/10.1038/ncb2548
  • Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 2006; 20:1218-49; PMID:16702400; http://dx.doi.org/10.1101/gad.1415606
  • Rosenblum WI. Histopathologic clues to the pathways of neuronal death following ischemia/hypoxia. J Neurotrauma 1997; 14:313-26; PMID:9199397; http://dx.doi.org/10.1089/neu.1997.14.313
  • Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53:549-54; PMID:2453289; http://dx.doi.org/10.1016/0092-8674(88)90571-5
  • Oosterom I, van Amersfoort M, Szuhai K, Lockley M, Offerhaus JG, Voest E, et al. Gemcitabine-induced invasion of pancreatic ductal adenocarcinoma in an accelerated genetically engineered Kras/P53 mouse model. submitted
  • Ritsma L, Steller EJ, Ellenbroek SI, Kranenburg O, Borel Rinkes IH, van Rheenen J. Surgical implantation of an abdominal imaging window for intravital microscopy. Nat Protoc 2013; 8:583-94; PMID:23429719; http://dx.doi.org/10.1038/nprot.2013.026
  • Scheele CLGJ, Maynard C, Van Rheenen J. Intravital insights into heterogeneity, metastasis, and therapy response. Trends in Cancer in press
  • Condeelis J, Singer RH, Segall JE. The great escape: when cancer cells hijack the genes for chemotaxis and motility. Ann Rev Cell Dev Biol 2005; 21:695-718; PMID:16212512; http://dx.doi.org/10.1146/annurev.cellbio.21.122303.120306
  • Beerling E, Seinstra D, de Wit E, Kester L, van der Velden D, Maynard C, Schäfer R, van Diest P, Voest E, van Oudenaarden A, et al. Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity. Cell Rep 2016; 14(10):2281-8; PMID:26947068; http://dx.doi.org/10.1016/j.celrep.2016.02.034
  • Pegtel DM, Ellenbroek SI, Mertens AE, van der Kammen RA, de Rooij J, Collard JG. The Par-Tiam1 complex controls persistent migration by stabilizing microtubule-dependent front-rear polarity. Curr Biol 2007; 17:1623-34; PMID:17825562; http://dx.doi.org/10.1016/j.cub.2007.08.035
  • Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell biol 2009; 11:1287-96; PMID:19838175; http://dx.doi.org/10.1038/ncb1973
  • Wyckoff JB, Jones JG, Condeelis JS, Segall JE. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res 2000; 60:2504-11; PMID:10811132
  • Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003; 3:921-30; PMID:14737122; http://dx.doi.org/10.1038/nrc1231
  • Bzymek R, Horsthemke M, Isfort K, Mohr S, Tjaden K, Muller-Tidow C, Thomann M, Schwerdtle T, Bähler M, Schwab A, et al. Real-time two- and three-dimensional imaging of monocyte motility and navigation on planar surfaces and in collagen matrices: roles of Rho. Sci Rep 2016; 6:25016; PMID:27122054; http://dx.doi.org/10.1038/srep25016
  • Zanier ER, Fumagalli S, Perego C, Pischiutta F, De Simoni MG. Shape descriptors of the “never resting” microglia in three different acute brain injury models in mice. Intensive Care Med Exp 2015; 3:39; PMID:26215806; http://dx.doi.org/10.1186/s40635-015-0039-0
  • Yu H, Tay CY, Leong WS, Tan SC, Liao K, Tan LP. Mechanical behavior of human mesenchymal stem cells during adipogenic and osteogenic differentiation. Biochem Biophys Res Commun 2010; 393:150-5; PMID:20117089; http://dx.doi.org/10.1016/j.bbrc.2010.01.107
  • Zaman MH, Trapani LM, Sieminski AL, Mackellar D, Gong H, Kamm RD, Wells A, Lauffenburger DA, Matsudaira P. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci U S A 2006; 103:10889-94; PMID:16832052; http://dx.doi.org/10.1073/pnas.0604460103
  • Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008; 135:510-23; PMID:18984162; http://dx.doi.org/10.1016/j.cell.2008.09.043
  • Huang YL, Tung CK, Zheng A, Kim BJ, Wu M. Interstitial flows promote amoeboid over mesenchymal motility of breast cancer cells revealed by a three dimensional microfluidic model. Integr Biol 2015; 7:1402-11; PMID:26235230; http://dx.doi.org/10.1039/C5IB00115C
  • Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Bröcker EB, Friedl P. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003; 160:267-77; PMID:12527751; http://dx.doi.org/10.1083/jcb.200209006
  • Friedl P, Hegerfeldt Y, Tusch M. Collective cell migration in morphogenesis and cancer. Int J Dev Biol 2004; 48:441-9; PMID:15349818; http://dx.doi.org/10.1387/ijdb.041821pf
  • Hirata E, Park D, Sahai E. Retrograde flow of cadherins in collective cell migration. Nat Cell Biol 2014; 16:621-3; PMID:24981633; http://dx.doi.org/10.1038/ncb2995
  • Wormann SM, Song L, Ai J, Diakopoulos KN, Gorgulu K, Ruess D, Campbell A, Doglioni C, Jodrell D, Neesse A, et al. Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and is Associated With Patient Survival. Gastroenterology 2016; 151:180-93.e12; http://dx.doi.org/10.1053/j.gastro.2016.03.010
  • Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 2012; 21:418-29; PMID:22439937; http://dx.doi.org/10.1016/j.ccr.2012.01.007